Menu
← Oncology Approval Tracker
FDA DECISION ·
Nelarabine (generic Arranon)
nelarabine · Zydus Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic nelarabine injection for adults and children age 1 and older with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma after at least two failed chemotherapy regimens.
LAMPGEN ANALYSIS
Why it matters
The approval covers the same later-line T-cell leukemia and lymphoma populations as the reference drug.
What research teams should watch
Track prior regimen count and neurologic baseline assessments and verify vial concentration at preparation.
PRIMARY RECORDS